Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by RazeKreationson Oct 28, 2020 12:27pm
59 Views
Post# 31795976

RE:Market not good

RE:Market not goodthe market may not be good for a lot of companies because of the surge in coronavirus cases but Microbix should not be included in that list. It is because of Covid 19 that Microbix has gained worldwide recognition and has become a world leader in diagnostic accuracy testing and training. As in good times and bad times there are always losers and winners and now is no different. Now that Microbix has and is gaining reputation and expanding production they are in a very good position to dramatically grow. And it only gets better when the pandemic starts to subside and all the other diagnostic testing products resume. 
<< Previous
Bullboard Posts
Next >>